ethyl 2-cyanoacrylate has been researched along with Pain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruckner, T; Debus, J; Habl, G; Hassel, J; Indorf, M; Jäger, D; Potthoff, K; Suppan, C | 1 |
1 trial(s) available for ethyl 2-cyanoacrylate and Pain
| Article | Year |
|---|---|
Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial.
Topics: Antibodies, Monoclonal, Humanized; Cetuximab; Cyanoacrylates; Drug-Related Side Effects and Adverse Reactions; ErbB Receptors; Head and Neck Neoplasms; Humans; Pain; Quality of Life; Radioimmunotherapy; Skin Diseases | 2014 |